Skip to main content
Top
Published in:

18-12-2024 | Lymphoma | Case Report

Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltration

Authors: Satoshi Ichikawa, Hiroki Kato, Naoya Morota, Hiroaki Abe, Akihisa Kawajiri, Kyoko Inokura, Koichi Onodera, Yasushi Onishi, Noriko Fukuhara, Satoko Sato, Fumiyoshi Fujishima, Ryo Ichinohasama, Hideo Harigae

Published in: Annals of Hematology | Issue 1/2025

Login to get access

Abstract

Although rearrangement of the MYC oncogene (MYC-R) is frequently observed in aggressive B-cell lymphomas, it is extremely rare in T-cell malignancies. A 64-year-old man who had been under observation for several years because of asymptomatic pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALToma) was admitted to our hospital because of poor general condition and hypotension. Blood tests revealed thrombocytopenia and elevated serum lactate dehydrogenase levels, whereas computed tomography revealed systemic lymphadenopathy and splenomegaly. An inguinal lymph node biopsy precipitated a diagnosis of angioimmunoblastic T-cell lymphoma (AITL). Shortly after admission, the patient experienced spontaneous intestinal perforation and hemorrhage caused by multiple intestinal infiltrations of the AITL. Although chemotherapy was administered, the patient died several weeks after admission. A 46,XY,t(8;14)(q24;q11.2) karyotype was identified, and fluorescence in situ hybridization analyses showed split signals for the MYC and T-cell receptor (TCR) alpha genes, by which a TCR::MYC translocation was confirmed. Pathological autopsy analysis revealed systemic infiltration of the AITL and no MALToma lesions. Only a few cases of mature T-cell lymphoma harboring MYC-R have been reported in the literature thus far. To the best of our knowledge, this is the first reported case of AITL with TCR::MYC rearrangement. This condition could be associated with refractoriness to chemotherapy and aggressive clinical course with systemic infiltration that included the intestine.
Appendix
Available only for authorised users
Literature
1.
go back to reference Manso R, Bellas C, Martin-Acosta P et al (2016) C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas. Haematologica 101:e336-338CrossRefPubMedPubMedCentral Manso R, Bellas C, Martin-Acosta P et al (2016) C-MYC is related to GATA3 expression and associated with poor prognosis in nodal peripheral T-cell lymphomas. Haematologica 101:e336-338CrossRefPubMedPubMedCentral
2.
go back to reference Peng Y, Yan H, Wang J, Zhang M, He J (2022) The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma. Acta Biochim Pol 69:559–565PubMed Peng Y, Yan H, Wang J, Zhang M, He J (2022) The clinicopathological characteristics of C-MYC protein in angioimmunoblastic T-cell lymphoma. Acta Biochim Pol 69:559–565PubMed
3.
go back to reference La Starza R, Borga C, Barba G et al (2014) Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations. Blood 124:3577–3582CrossRefPubMed La Starza R, Borga C, Barba G et al (2014) Genetic profile of T-cell acute lymphoblastic leukemias with MYC translocations. Blood 124:3577–3582CrossRefPubMed
4.
go back to reference Parolini M, Mecucci C, Matteucci C et al (2014) Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and long-term survival in an adult patient. Blood Cancer J 4:e176CrossRefPubMedPubMedCentral Parolini M, Mecucci C, Matteucci C et al (2014) Highly aggressive T-cell acute lymphoblastic leukemia with t(8;14)(q24;q11): extensive genetic characterization and achievement of early molecular remission and long-term survival in an adult patient. Blood Cancer J 4:e176CrossRefPubMedPubMedCentral
5.
go back to reference Zhang X, Wang T, Zhang Y et al (2023) Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation. Leuk Lymphoma 64:2133–2139CrossRefPubMed Zhang X, Wang T, Zhang Y et al (2023) Characteristics and therapeutic approaches for patients diagnosed with T-ALL/LBL exhibiting t(8;14)(q24;q11)/TCRA/D:MYC translocation. Leuk Lymphoma 64:2133–2139CrossRefPubMed
6.
go back to reference Monaco S, Tsao L, Murty VV et al (2007) Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase. Am J Hematol 82:59–64CrossRefPubMed Monaco S, Tsao L, Murty VV et al (2007) Pediatric ALK+ anaplastic large cell lymphoma with t(3;8)(q26.2;q24) translocation and c-myc rearrangement terminating in a leukemic phase. Am J Hematol 82:59–64CrossRefPubMed
7.
go back to reference Moritake H, Shimonodan H, Marutsuka K, Kamimura S, Kojima H, Nunoi H (2011) C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC. Am J Hematol 86:75–78CrossRefPubMed Moritake H, Shimonodan H, Marutsuka K, Kamimura S, Kojima H, Nunoi H (2011) C-MYC rearrangement may induce an aggressive phenotype in anaplastic lymphoma kinase positive anaplastic large cell lymphoma: Identification of a novel fusion gene ALO17/C-MYC. Am J Hematol 86:75–78CrossRefPubMed
8.
go back to reference Liang X, Branchford B, Greffe B et al (2013) Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol 35:e209-213CrossRefPubMed Liang X, Branchford B, Greffe B et al (2013) Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma. J Pediatr Hematol Oncol 35:e209-213CrossRefPubMed
9.
go back to reference Luo DX, Li W, Ye MT, Yang Y, Tang G, You MJ (2020) “Double hit” anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements. Am J Hematol 95:1625–1627CrossRefPubMed Luo DX, Li W, Ye MT, Yang Y, Tang G, You MJ (2020) “Double hit” anaplastic large cell lymphoma with concurrent ALK and MYC rearrangements. Am J Hematol 95:1625–1627CrossRefPubMed
10.
go back to reference Khanlari M, Tang G, Hao S et al (2021) Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192:e17–e21CrossRefPubMed Khanlari M, Tang G, Hao S et al (2021) Anaplastic lymphoma kinase (ALK)-negative anaplastic large cell lymphoma with MYC rearrangement. Br J Haematol 192:e17–e21CrossRefPubMed
11.
go back to reference Okumura K, Ikebe M, Shimokama T et al (2012) An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report. World J Gastroenterol 18:2434–2437CrossRefPubMedPubMedCentral Okumura K, Ikebe M, Shimokama T et al (2012) An unusual enteropathy-associated T-cell lymphoma with MYC translocation arising in a Japanese patient: a case report. World J Gastroenterol 18:2434–2437CrossRefPubMedPubMedCentral
12.
go back to reference Ott G, Rosenwald A, Campo E (2013) Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood 122:3884–3891CrossRefPubMed Ott G, Rosenwald A, Campo E (2013) Understanding MYC-driven aggressive B-cell lymphomas: pathogenesis and classification. Blood 122:3884–3891CrossRefPubMed
13.
go back to reference Dogan A, Gaulard P, Jaffe ES, Müller-Hermelink HK, de Leval L (2017) Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper cell origin. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised, 4th edn. International Agency for Research on Cancer, Lyon, pp 407–412 Dogan A, Gaulard P, Jaffe ES, Müller-Hermelink HK, de Leval L (2017) Angioimmunoblastic T-cell lymphoma and other nodal lymphomas of T follicular helper cell origin. In: Swerdlow SH et al (eds) WHO classification of tumours of haematopoietic and lymphoid tissues, revised, 4th edn. International Agency for Research on Cancer, Lyon, pp 407–412
14.
go back to reference Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1:1070–1073CrossRefPubMed Frizzera G, Moran EM, Rappaport H (1974) Angio-immunoblastic lymphadenopathy with dysproteinaemia. Lancet 1:1070–1073CrossRefPubMed
15.
go back to reference Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8CrossRefPubMed Lukes RJ, Tindle BH (1975) Immunoblastic lymphadenopathy. A hyperimmune entity resembling Hodgkin’s disease. N Engl J Med 292:1–8CrossRefPubMed
16.
go back to reference Cullen MH, Stansfeld AG, Oliver RT, Lister TA, Malpas JS (1979) Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med 48:151–177PubMed Cullen MH, Stansfeld AG, Oliver RT, Lister TA, Malpas JS (1979) Angio-immunoblastic lymphadenopathy: report of ten cases and review of the literature. Q J Med 48:151–177PubMed
17.
go back to reference Schauer PK, Straus DJ, Bagley CM Jr et al (1981) Angioimmunoblastic lymphadenopathy: clinical spectrum of disease. Cancer 48:2493–2498CrossRefPubMed Schauer PK, Straus DJ, Bagley CM Jr et al (1981) Angioimmunoblastic lymphadenopathy: clinical spectrum of disease. Cancer 48:2493–2498CrossRefPubMed
18.
go back to reference Rosenstein ED, Rickert RR, Gutkin M, Bacay A, Kramer N (1988) Colonic involvement in angioimmunoblastic lymphadenopathy resembling inflammatory bowel disease. Cancer 61:2244–2250CrossRefPubMed Rosenstein ED, Rickert RR, Gutkin M, Bacay A, Kramer N (1988) Colonic involvement in angioimmunoblastic lymphadenopathy resembling inflammatory bowel disease. Cancer 61:2244–2250CrossRefPubMed
19.
go back to reference Turan I, Ozsan N, Doganavsargil B, Davulcu EA, Bulbul H (2020) The first report of colonic involvement of angioimmunoblastic T-cell lymphoma. Turk J Gastroenterol 31:413–414CrossRefPubMedPubMedCentral Turan I, Ozsan N, Doganavsargil B, Davulcu EA, Bulbul H (2020) The first report of colonic involvement of angioimmunoblastic T-cell lymphoma. Turk J Gastroenterol 31:413–414CrossRefPubMedPubMedCentral
20.
go back to reference Tang XF, Yang L, Duan S, Guo H, Guo QN (2018) Intestinal T-cell and NK/T-cell lymphomas: A clinicopathological study of 27 Chinese patients. Ann Diagn Pathol 37:107–117CrossRefPubMed Tang XF, Yang L, Duan S, Guo H, Guo QN (2018) Intestinal T-cell and NK/T-cell lymphomas: A clinicopathological study of 27 Chinese patients. Ann Diagn Pathol 37:107–117CrossRefPubMed
Metadata
Title
Angioimmunoblastic T-cell lymphoma harboring a t(8;14)(q24;q11.2)/TCR::MYC translocation that presented with intestinal infiltration
Authors
Satoshi Ichikawa
Hiroki Kato
Naoya Morota
Hiroaki Abe
Akihisa Kawajiri
Kyoko Inokura
Koichi Onodera
Yasushi Onishi
Noriko Fukuhara
Satoko Sato
Fumiyoshi Fujishima
Ryo Ichinohasama
Hideo Harigae
Publication date
18-12-2024
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 1/2025
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-024-06148-2

Elevate your expertise in aplastic anemia (Link opens in a new window)

Transform the way you care for your patients with aplastic anemia with our 3-module series using real-world case studies and expert insights. Discover why early diagnosis matters, explore the benefits and risks of current treatments, and develop tailored approaches for complex cases. 

Supported by:
  • Pfizer
Developed by: Springer Healthcare IME
Learn more

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now
Video